Filed Patent Application for its proprietary Method of Manufacturing Stromal Vascular Fraction Cells Read more…
The bill that would ease deadlines for seeking a patent-term extension granted to compensate drug makers for the time it takes to get regulatory approval. Read more…
Patent for compositions for the formulation of stem cell therapies Read more…
CUR received notification that the US Patent and Trademark Office (USPTO) upholding the patentability, without amendment, Read more…
Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.